lornoxicam and Gastrointestinal-Hemorrhage

lornoxicam has been researched along with Gastrointestinal-Hemorrhage* in 2 studies

Other Studies

2 other study(ies) available for lornoxicam and Gastrointestinal-Hemorrhage

ArticleYear
Presumptive Lornoxicam Intoxication in Four Dogs.
    Topics in companion animal medicine, 2021, Volume: 42

    Lornoxicam is a nonsteroidal anti-inflammatory drug extensively used in human medicine, which is not approved for canine use. Lornoxicam intoxication has been rarely reported in dogs. Four dogs of various breeds, aged 7 months to 10 years, were admitted with a recent history of melena, anorexia and depression, occurring 1-4 days after the ingestion of lornoxicam (dose range: 0.53-2.7 [median 1.17] mg/kg). No clinically relevant comorbidities were documented, but low doses of prednisolone had been given in 3 of the dogs, in close temporal association with lornoxicam. Major clinical and clinicopathologic findings on admission included mucosal pallor, melena, depression, severe anemia, neutrophilic leucocytosis, and panhypoproteinemia. Perforated pyloric and duodenal ulcers were documented in 3 dogs by exploratory celiotomy or postmortem. Prolonged hospitalization (5-20 days) with extensive supportive care and multiple blood transfusions was required in 3 of the 4 dogs who survived to discharge. Lornoxicam ingestion may cause protracted and severe gastrointestinal tract injury and bleeding, blood loss anemia, panhypoproteinemia, and perforated gastrointestinal ulcers, associated with significant morbidity and mortality in dogs.

    Topics: Anemia; Animals; Anti-Inflammatory Agents, Non-Steroidal; Digestive System; Dog Diseases; Dogs; Gastrointestinal Diseases; Gastrointestinal Hemorrhage; Piroxicam

2021
[Severe gastrointestinal bleeding secondary to lornoxicam in the dog].
    Schweizer Archiv fur Tierheilkunde, 2011, Volume: 153, Issue:5

    Six dogs with lornoxicam induced severe gastrointestinal bleeding are described. The ingested dose ranged between 0.5 - 5.1 mg/kg BW (median 0.63 mg/kg BW). The severity of the bloodloss anemia was moderate to severe with PCV values ranging between 12 - 27 % (median 16 %) and serum albumin concentrations between 12 - 22 g/l (median 16 g/l). One dog had evidence of chronic thrombocytopathia over 13 days and clinicopathologic findings of gastrointestinal bleeding over 55 days. None of the dogs developed kidney injuries. The clinical condition required transfusion of blood products in 5 of 6 cases. One dog with a perforated duodenal ulcer and septic peritonitis survived until discharge but had to be euthanized later on due to recrudescent clinical signs (hematemesis, melena). The median length of hospitalisation was 12 days (5 - 14). No correlation was seen between the ingested dose and severity of clinical signs. Lornoxicam ingestion leads to severe and longlasting gastrointestinal bleeding in the dog and requires immediate intensive therapy.

    Topics: Anemia; Animals; Anti-Inflammatory Agents, Non-Steroidal; Blood Component Transfusion; Dog Diseases; Dogs; Female; Gastrointestinal Hemorrhage; Hematocrit; Length of Stay; Male; Piroxicam; Serum Albumin

2011